Pharmaceuticals Analysts discuss JPMorgan’s Alzheimer’s Survey on an Analyst/Industry conference call to be held on December 20 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BIIB:
- QQQ ETF Update, 12/20/2023
- Biogen: EC revokes centralized marketing authorizations for TECFIDERA generics
- Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European Commission
- CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia, a Rare Neurodegenerative Disease
- Biogen reports CHMP issues positive opinion for SKYCLARYS